0001609351-19-000004.txt : 20190104 0001609351-19-000004.hdr.sgml : 20190104 20190104160423 ACCESSION NUMBER: 0001609351-19-000004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190103 FILED AS OF DATE: 20190104 DATE AS OF CHANGE: 20190104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PEREZ ROBERT J CENTRAL INDEX KEY: 0001263230 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36819 FILM NUMBER: 19510001 MAIL ADDRESS: STREET 1: C/O AMAG PHARMACEUTICALS, INC. STREET 2: 1100 WINTER ST. CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Spark Therapeutics, Inc. CENTRAL INDEX KEY: 0001609351 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 462654405 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3737 MARKET STREET STREET 2: SUITE 1300 CITY: PHILADELPHIA STATE: PA ZIP: 19104 BUSINESS PHONE: 888-772-7560 MAIL ADDRESS: STREET 1: 3737 MARKET STREET STREET 2: SUITE 1300 CITY: PHILADELPHIA STATE: PA ZIP: 19104 4 1 wf-form4_154663584200619.xml FORM 4 X0306 4 2019-01-03 0 0001609351 Spark Therapeutics, Inc. ONCE 0001263230 PEREZ ROBERT J C/O SPARK THERAPEUTICS, INC. 3737 MARKET STREET, SUITE 1300 PHILADELPHIA PA 19104 1 0 0 0 Common Stock 2019-01-03 4 M 0 1000 A 1000 D Restricted Stock Units 2019-01-03 4 M 0 1000 0 D Common Stock 1000.0 2000 D Each restricted stock unit represents a contingent right to receive one share of Spark Therapeutics, Inc. common stock. On January 3, 2018, the reporting person was granted 3,000 restricted stock units that vest in three equal annual installments beginning January 3, 2019. Vested shares will be delivered to the reporting person annually on the vesting date. /s/ Joseph W. La Barge, attorney-in-fact for Robert J. Perez 2019-01-04